RESUMEN
BACKGROUND: Regression of thrombus in response to treatment with direct oral anticoagulants (DOACs) in patients with extensive deep vein thrombosis (DVT) has not been fully evaluated. This study aimed to determine the therapeutic efficacy of rivaroxaban in the treatment of extensive DVT. METHODS: We retrospectively evaluated 76 patients treated with rivaroxaban among 728 new DVT patients, at our hospital from January 2018 to March 2021. Extensive DVT was defined as thrombus connecting to 2 or more segments of the inferior vena cava (IVC), iliac vein, femoral vein, or popliteal vein. Localized DVT was defined as a thrombus confined to 1 segment of the inferior vena cava (IVC), iliac vein, femoral vein, or popliteal vein. We compared the changes in thrombus between the extensive DVT group (36 patients) and the localized DVT group (40 patients). RESULTS: In the localized DVT group, 14 (37%) had total recanalization within 3 weeks after DOAC initiation, and 30 (79%) had total recanalization within 3 months. In the extensive DVT group, only 3 (9%) had total recanalization within 3 weeks after starting DOAC, and even after 3 months, only 5 (15%) had total recanalization. Symptoms (P = 0.01) and extensive DVT (P < 0.01) were significantly associated with the risk for failure of total recanalization. CONCLUSIONS: Rivaroxaban was highly effective for total recanalization of localized DVT but not for symptomatic or extensive DVT. In patients with symptomatic extensive DVT, catheter-based thrombolysis may be considered in selected cases.
Asunto(s)
Trombosis , Trombosis de la Vena , Anticoagulantes/efectos adversos , Humanos , Vena Ilíaca/diagnóstico por imagen , Estudios Retrospectivos , Rivaroxabán/efectos adversos , Terapia Trombolítica/efectos adversos , Trombosis/etiología , Resultado del Tratamiento , Trombosis de la Vena/complicaciones , Trombosis de la Vena/diagnóstico por imagen , Trombosis de la Vena/tratamiento farmacológicoRESUMEN
Prevalence of myopia is increasing worldwide. Outdoor activity is one of the most important environmental factors for myopia control. Here we show that violet light (VL, 360-400nm wavelength) suppresses myopia progression. First, we confirmed that VL suppressed the axial length (AL) elongation in the chick myopia model. Expression microarray analyses revealed that myopia suppressive gene EGR1 was upregulated by VL exposure. VL exposure induced significantly higher upregulation of EGR1 in chick chorioretinal tissues than blue light under the same conditions. Next, we conducted clinical research retrospectively to compare the AL elongation among myopic children who wore eyeglasses (VL blocked) and two types of contact lenses (partially VL blocked and VL transmitting). The data showed the VL transmitting contact lenses suppressed myopia progression most. These results suggest that VL is one of the important outdoor environmental factors for myopia control. Since VL is apt to be excluded from our modern society due to the excessive UV protection, VL exposure can be a preventive strategy against myopia progression.
Asunto(s)
Luz , Miopía/diagnóstico , Miopía/terapia , Fototerapia , Adolescente , Animales , Línea Celular , Pollos , Niño , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Anteojos , Expresión Génica , Perfilación de la Expresión Génica , Humanos , Masculino , Miopía/etiología , Refracción Ocular , Luz Solar , Resultado del Tratamiento , Rayos UltravioletaRESUMEN
PURPOSE: We retrospectively compared the short-term outcomes between incision and drainage (ID) and hainosankyuto (TJ-122, Tsumura & Co, Tokyo, Japan) treatment for perianal abscess (PA) in infants. METHODS: We retrospectively examined 48 consecutive patients (median age 129 days; range 19-330 days) who presented with PA over a 3 year period. Group 1 comprised 26 patients who were treated with ID at presentation, and Group 2 comprised 22 patients who were treated with oral TJ-122 at presentation; oral treatment was continued until the disappearance of purulent discharge and resolution of induration at the abscess site. RESULTS: PAs were identified in all 48 patients at presentation. The median duration of follow-up was 26 months (range 13-40 months). At presentation, there were no differences in the gender, age, birth weight, duration of symptoms, skin erosion or prevalence of diarrhea between the two groups. Purulent discharge resolved within a median period of 26 days (range 7-42 days) in Group 2, but persisted for 40 days (range 4-196 days) in Group 1. The induration resolved within a median period of 39 days (range 7-91 days) in Group 2, but persisted for 70 days (range 4-308 days) in Group 1 (p = 0.04). CONCLUSIONS: TJ-122 treatment was more beneficial than ID in treating PA in infants.
Asunto(s)
Absceso/terapia , Enfermedades del Ano/terapia , Procedimientos Quirúrgicos del Sistema Digestivo , Drenaje , Medicamentos Herbarios Chinos/administración & dosificación , Fitoterapia , Administración Oftálmica , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Estudios Retrospectivos , Factores de Tiempo , Resultado del TratamientoRESUMEN
There is an increasing interest in dietary polyphenols for risk reduction in cardiovascular diseases. The aim of this study was to evaluate acute and chronic flow-mediated dilation (FMD) and blood pressure responses to daily intake of boysenberry juice. FMD of the brachial artery was measured in six subjects in the initial, intermediate and follow-up stages of a 4-week open-label intervention study. The intake of boysenberry juice (180 ml/d) increased FMD with progression of intervention stage, and FMD differed in the follow-up stage compared with pre-intake baseline (p = 0.0163 < 0.0167 = 0.1/6) using Bonferroni correction. Changes in systolic blood pressure (SBP) correlated negatively with SBP before intake only in the follow-up stage (r = -0.961 and p = 0.0007 at 3.5 h), indicating a greater SBP reduction in subjects with higher SBP. These results suggest that daily intake of boysenberry juice is beneficial for reducing cardiovascular risk.
Asunto(s)
Presión Sanguínea/efectos de los fármacos , Enfermedades Cardiovasculares/prevención & control , Frutas/química , Hipertensión/dietoterapia , Polifenoles/farmacología , Rosaceae/química , Vasodilatación/efectos de los fármacos , Adulto , Anciano , Bebidas , Presión Sanguínea/fisiología , Arteria Braquial , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/fisiopatología , Dilatación Patológica , Femenino , Humanos , Hipertensión/fisiopatología , Masculino , Persona de Mediana Edad , Fitoterapia , Preparaciones de Plantas/farmacología , Factores de RiesgoRESUMEN
INTRODUCTION: Terpene trilactones (TTLs), unique components of Ginkgo biloba extracts, are believed to play important roles in the biological activity of these materials. The investigation of seasonal and gender-related variations in the natural content of TTLs in the leaves is a challenging problem that must be addressed in order to establish more efficient extraction/isolation protocols for TTLs. OBJECTIVE: The aims of this work were (i) to modify the extraction/isolation protocols of TTLs from G. biloba leaves by means of boiling and filtration procedures, and (ii) to investigate seasonal and gender-related variations in the TTL content of the leaves via (1) H-NMR analysis. METHODOLOGY: When extracting TTLs from G. biloba leaves, procedures for boiling and filtration were improved in this work. Moreover, quantitative (1) H-NMR analysis using DMF as a reference was performed and correlated to the colour (green/yellow) and gender (male/female) variations in the natural compositions of TTLs in the leaves. RESULTS: Extraction procedures were modified to include boiling in ethyl acetate and filtration was achieved with celite. (1) H-NMR analysis of TTLs suggested that green female leaves contained the largest amount of TTLs, while no TTLs were present in yellow male leaves. CONCLUSION: The present results provide a method for quickly supplying laboratory-scale quantities of TTLs from natural sources to enable the study of their structure-activity relationships.
Asunto(s)
Ginkgo biloba/química , Lactonas/análisis , Extractos Vegetales/química , Hojas de la Planta/química , Terpenos/análisis , Acetatos/química , Peróxido de Hidrógeno/química , Lactonas/química , Lactonas/aislamiento & purificación , Espectroscopía de Resonancia Magnética , Medicina Tradicional China , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales/química , Estaciones del Año , Relación Estructura-Actividad , Temperatura , Terpenos/química , Terpenos/aislamiento & purificaciónRESUMEN
PURPOSE: To review the clinical features and management of circumscribed choroidal hemangioma. METHODS: Twenty eight cases of circumscribed choroidal hemangioma diagnosed at Tokyo Medical University Hospital from 1991 through 2008 were reviewed. We retrospectively studied the frequency of the individual tumors, gender, age, size of tumors, presence of serous detachment and hyperopia, management and outcome. RESULTS: Sixteen patients were men and 12 cases were women. The average age was 55 years. The average basal diameter of the tumors was 3.3 optic disc. Serous retinal detachment was observed in 19 cases (70%). Seventeen eyes agreed with the definition of hyperopia, 10 cases (59%) developed hyperopia. Thirteen cases (46%) were observed without any treatment, 10 cases(36%) were treated with transpupillary thermotherapy (TTT) and 5 cases (18%) were treated with dye laser. Thirteen cases (46%) showed improvement, 13 cases (46%) remained constant and 2 cases (7%) showed deterioration. CONCLUSION: Circumscribed choroidal hemangioma is a relatively rare clinical entity. The management should be tailored to the individual patients including the tumor size presence of serous detachement and visual acuity.
Asunto(s)
Neoplasias de la Coroides , Hemangioma , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Coroides/patología , Neoplasias de la Coroides/fisiopatología , Neoplasias de la Coroides/terapia , Femenino , Hemangioma/patología , Hemangioma/fisiopatología , Hemangioma/terapia , Humanos , Hiperopía , Hipertermia Inducida , Láseres de Colorantes , Masculino , Persona de Mediana Edad , Pronóstico , Desprendimiento de Retina , Estudios Retrospectivos , Agudeza Visual , Adulto JovenRESUMEN
Indigestible oligosaccharides have been shown to normalize blood glucose and insulin concentration thereby promoting good health and preventing diseases, such as diabetes. Transglucosidase (TG, alpha-glucosidase, enzyme code (EC) 3.2.1.20) is an enzyme capable of converting starch to oligosaccharides, such as iso-malto-oligosaccharides from maltose, via the action of amylase. The aim of this study was to evaluate whether oral administration of TG with maltose or dextrin is capable of reducing post-prandial serum glucose concentration in experimentally streptozotocin (STZ)-induced diabetic dogs fed on a high-fiber diet. Five healthy and five STZ-induced diabetic dogs were employed in this study. TG supplementation with dextrin or maltose had no detrimental effect in healthy dogs. In fact, TG and dextrin exhibited a flatlined serum glucose pattern, while reducing mean post-prandial serum insulin and glucose concentration as compared to control diet alone. When TG supplementation was tested in STZ-induced diabetic dogs under the context of a high fiber diet, a 13.8% and 23.9% reduction in mean glucose concentration for TG with maltose and dextrin, respectively was observed. Moreover, TG with dextrin resulted in a 13% lower mean post-prandial glucose concentration than TG with maltose, suggesting that dextrin may be a more efficient substrate than maltose when used at the same concentration (1 g/kg). Our results indicate that TG supplementation with diet can lead to lower postprandial glucose levels versus diet alone. However, the efficacy of TG supplementation may depend on the type of diet it is supplemented with. As such, TG administration may be useful for preventing the progression of diabetes mellitus and in its management in dogs.
Asunto(s)
Diabetes Mellitus Experimental/prevención & control , Diabetes Mellitus Tipo 1/veterinaria , Fibras de la Dieta/administración & dosificación , Enfermedades de los Perros/dietoterapia , Glucosidasas/administración & dosificación , Hiperglucemia/veterinaria , Animales , Área Bajo la Curva , Glucemia/metabolismo , Dextrinas/administración & dosificación , Dextrinas/metabolismo , Diabetes Mellitus Experimental/dietoterapia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/dietoterapia , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/prevención & control , Fibras de la Dieta/metabolismo , Suplementos Dietéticos , Enfermedades de los Perros/metabolismo , Enfermedades de los Perros/prevención & control , Perros , Femenino , Glucosidasas/metabolismo , Hiperglucemia/metabolismo , Hiperglucemia/prevención & control , Insulina/sangre , Masculino , Maltosa/administración & dosificación , Maltosa/metabolismoRESUMEN
Clinical application of artificial oxygen carriers as a substitute for blood transfusion has long been expected to solve some of the problems associated with blood transfusion. Use for oxygen delivery treatment for ischemic disease by oxygen delivery has also been examined. These prospective applications of artificial oxygen carriers are, however, still in development. We have developed liposome-encapsulated hemoglobin (LEH), developmental code TRM-645, using technologies for encapsulation of concentrated hemoglobin (Hb) with high encapsulation efficiency as well as surface modification to achieve stability in circulating blood and a long shelf life. We have confirmed the basic efficacy and safety of TRM-645 as a red blood cell substitute in studies on the efficacy of oxygen delivery in vivo, and the safety of TRM-645 has been studied in some animal species. We are now examining various issues related to clinical studies, including further preclinical studies, management of manufacturing and the quality assurance for the Hb solution and liposome preparations manufactured by the GMP facility.
Asunto(s)
Sustitutos Sanguíneos/administración & dosificación , Sustitutos Sanguíneos/farmacología , Animales , Sustitutos Sanguíneos/química , Sustitutos Sanguíneos/farmacocinética , Ensayos Clínicos como Asunto , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Humanos , Liposomas , Oxígeno/metabolismoRESUMEN
BACKGROUND: There are only a few reports discussing the characteristics of intussusception developing in school-age children. The characteristics of these cases are discussed, with reference to previous literature. METHODS: The present study included eight cases of intussusception in school-age children among 143 intussusception patients treated on an inpatient basis at Nihon University Itabashi Hospital, during the 11 year period from 1993 to 2003. The remaining 135 patients were assigned to the infant group as controls. The clinical characteristics of intussusception in school-age children were compared with those of the condition developing in infants. RESULTS: The eight children of school age with intussusception ranged in age from 8 to 15 years (mean, 11.6 years), and consisted of five boys and three girls. The major symptom was abdominal pain, occurring in 100% (8/8). Bloody stools and vomiting were reported in two patients each (25%) from this group. The triad of abdominal pain, bloody stools and vomiting was recognized in only one child (12.5%) of this group. Two children (25.0%) had a palpable abdominal mass, and one child (12.5%) complained of diarrhea. None of the school-age children with intussusception had any antecedent infection; five, two and one patients had the ileo-colic type, ileo-ileo-colic type and ileo-ileal type of intussusception, respectively. Four underwent enema reduction and four underwent surgical reduction. One of the eight children (12.5%) had underlying organic abnormality; in the remaining children the condition was labeled idiopathic. One child developed recurrences. CONCLUSIONS: In school-age children intussusception is generally believed to be commonly secondary to underlying organic abnormality, but in the present study only one of eight school-age children had underlying organic abnormality; in the remaining children, the condition was labeled idiopathic. The major symptom in school-age intussusception was abdominal pain. Therefore this may need to be differentiated from appendicitis in children of school age. It is considered that abdominal ultrasonography (USG) is a simple and useful method for making the diagnosis of intussusception, and that diagnostic USG should be conducted in all school-age children presenting with acute abdominal pain.